Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29370992

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2018 Mar
First author
D'Angelo SP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Mar;19(3):283-285. doi: 10.1016/S1470-2045(18)30039-1.
    note
    Source null
    related pmid
    29370991
    relationship
    Comment in

Authors and identifiers

  1. name
    D'Angelo SP
    type
    Author
  2. name
    Mahoney MR
    type
    Author
  3. name
    Van Tine BA
    type
    Author
  4. name
    Atkins J
    type
    Author
  5. name
    Milhem MM
    type
    Author
  6. name
    Jahagirdar BN
    type
    Author
  7. name
    Antonescu CR
    type
    Author
  8. name
    Horvath E
    type
    Author
  9. name
    Tap WD
    type
    Author
  10. name
    Schwartz GK
    type
    Author
  11. name
    Streicher H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    D'Angelo SP
    type
    Author
  2. name
    Mahoney MR
    type
    Author
  3. name
    Van Tine BA
    type
    Author
  4. name
    Atkins J
    type
    Author
  5. name
    Milhem MM
    type
    Author
  6. name
    Jahagirdar BN
    type
    Author
  7. name
    Antonescu CR
    type
    Author
  8. name
    Horvath E
    type
    Author
  9. name
    Tap WD
    type
    Author
  10. name
    Schwartz GK
    type
    Author
  11. name
    Streicher H
    type
    Author
bibliography ids
  1. nci-bib-b7e1b804d9f5f6757d17103e
book metadata
content sha256
8f38b59dccc7f7828b88ee3ab08eb4448a0d40bddac435e90ebc2e427a755c46
document type
citation
dois
  1. 10.1016/S1470-2045(18)30006-8
electronic publication date
display
2018 Jan 19
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29370992
immutable id
pubmed:29370992@8f38b59dccc7f7828b88ee3ab08eb4448a0d40bddac435e90ebc2e427a755c46
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
3
name
The Lancet. Oncology
nlm unique id
100957246
pages
416-426
volume
19
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2018 Mar;19(3):283-285. doi: 10.1016/S1470-2045(18)30039-1.
    note
    Source null
    related pmid
    29370991
    relationship
    Comment in
outcomes validated
false
pmid
29370992
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
c8c53d529e3c81e1e9a162987567187b5ce51905eddbb439e2d2ff3c76d42a2f
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Mar
precision
month
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29370992/
title
Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.

Preserved source evidence · Not medical advice